造影剤インジェクター市場 : 2029年までの世界予測

Report Overview

The global contrast media injectors market is expected to reach USD 2.3 billion by 2029 from USD 1.6 billion in 2024, at a CAGR of 8.0% from 2024 to 2029.

世界の造影剤インジェクター市場は、2024年から2029年までCAGR 8.0%で、2024年の16億ドルから2029年までに23億ドルに達すると予想されています。

Aging population, coupled with a rise in cancer and heart diseases, has increased the demand for these products. Cardiovascular diseases are more prevalent in old-age population. Contrast media helps to better visualize the blood vessels and improves diagnostic confidence. Moreover, increased benefits of contrast-mediated procedures have driven demand for contrast media injectors.

“The consumables segment of product segment held the largest share of the market in 2023”
The contrast media injectors market is segmented based on product into injector systems, consumables, and accessories. Contrast media consumables, like – syringes, tubing, vials and bottles, IV sets, etc., are the various products used to administer contrast agents for imaging procedures. The rising prevalence of chronic diseases and the growing demand for early diagnosis have led to an increase in diagnostic imaging procedures, boosting the demand for contrast media consumables.

“The dual-head injector segment of type segment held the largest share of the market in 2023”
The contrast media injectors market is segmented based on type into dual-head, single head, syringeless. The rising prevalence of heart diseases and growing opportunities in emerging countries drives this segment. There are number of companies providing contrast media injectors and consumables in China. Focus on innovation and strategies adopted by these players to expand their geographic presence offers lucrative opportunity for the growth of overall market. Dual-head injectors have notable benefits such as improved workflow efficiency and enhanced safety. The launch of new dual-head injectors in past few years has supported its adoption in end user facilities.

“The radiology segment for application segment to hold the largest market share in 2023”.
Based on application, the contrast media injectors market is segmented into interventional radiology, interventional cardiology, and radiology. Radiology was the major segment, accounting for the largest contrast media injectors market share in 2023. The rising incidence of chronic conditions is supported by the increasing aging population. This ultimately drives the adoption of contrast media injectors. A rising number of campaigns for the early detection of symptoms is also contributing to the increasing number of diagnostic imaging scans that ultimately support the adoption of contrast media injectors in end-user facilities.

“The diagnostic imaging centers segment for the end user segment is projected to register a significant CAGR during the forecast period.”
The contrast media injectors market is segmented by end-users into hospitals and diagnostic imaging centers. The hospitals accounted for a major end-user market share in 2023. The emphasis on minimally invasive treatment among the old-age population and increasing grants for the installation of advanced imaging equipment are driving the integration of contrast media injectors into hospital settings. Rising number of diagnostic imaging centers to fulfill the growing demand for imaging equipment and consistent rise in old-age population is expected to support the growth of this segment.

“The market in the Asia Pacific region is expected to witness the highest growth during the forecast period.”
Increased investment in healthcare infrastructure and services, especially in emerging economies, supports the expansion of diagnostic imaging and, consequently, the demand for contrast injectors. Key players in the market are focusing on expanding their presence in Asia Pacific market to cater the increasing demand for diagnostic scans. Moreover, the proliferation of diagnostic centers, particularly in APAC region, increases the availability and accessibility of imaging services, further driving the demand for contrast media injectors.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–30%, Tier 2–42%, and Tier 3– 28%
• By Designation: Director-level–10%, C-level–14%, and Others–76%
• By Region: North America–40%, Europe–30%, Asia Pacific–22%, Latin America–6%, and the Middle East & Africa–2%

The prominent players in the contrast media injectors market are Bayer AG (Germany), Bracco Imaging S.p.A. (Italy), Guerbet (France), Medtron AG (Germany), Ulrich GmbH & Co. Kg (Germany), and Nemoto Kyorindo (Japan), Sino MDT (China)among others.

Research Coverage
This report studies the contrast media injectors market based on product, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report
The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall contrast media injectors market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:
• Analysis of key drivers (increasing prevalence of cancer and cardiovascular diseases, growing adoption of contrast-mediated CT and MRI procedures, growing approvals of contrast media), restraints (high cost of contrast media injectors systems), opportunities (rising healthcare expenditure across emerging countries), and challenges (dearth of trained professionals) influencing the growth of the contrast media injectors market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the contrast media injectors market
• Market Development: Comprehensive information about lucrative markets–the report analyses the contrast media injectors market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the contrast media injectors market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as Bayer AG (Germany), Guerbet (France), Bracco Imaging S.p.A. (Italy), Ulrich GmbH & Co. Kg (Germany), Medtron AG (Germany), and Nemoto Kyorindo (Japan).

Table of Contents

1            INTRODUCTION            29

1.1         STUDY OBJECTIVES      29

1.2         MARKET DEFINITION   29

1.2.1      INCLUSIONS & EXCLUSIONS     30

1.3         MARKET SCOPE             30

1.3.1      MARKETS COVERED     30

1.3.2      YEARS CONSIDERED     31

1.3.3      CURRENCY CONSIDERED          31

1.4         STAKEHOLDERS            31

1.5         SUMMARY OF CHANGES            32

1.6         RECESSION IMPACT      32

2            RESEARCH METHODOLOGY     33

2.1         RESEARCH DATA           33

FIGURE 1           RESEARCH DESIGN       33

2.1.1      SECONDARY RESEARCH             34

2.1.2      PRIMARY RESEARCH     34

2.1.2.1   Primary sources   35

2.1.2.2   Key industry insights          36

2.1.2.3   Breakdown of primaries     36

FIGURE 2           BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 36

FIGURE 3           BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION    37

2.2         MARKET SIZE ESTIMATION       37

FIGURE 4           RESEARCH METHODOLOGY: HYPOTHESIS BUILDING  38

2.2.1      BOTTOM-UP APPROACH           38

2.2.1.1   Approach 1: Company revenue estimation approach    38

FIGURE 5           CONTRAST MEDIA INJECTORS MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)         39

2.2.1.2   Approach 2: Customer-based market estimation          39

FIGURE 6           CONTRAST MEDIA INJECTORS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH           40

2.2.1.3   Growth forecast   40

2.2.1.4   CAGR projections             40

FIGURE 7           CAGR PROJECTION: SUPPLY-SIDE ANALYSIS     40

2.3         DATA TRIANGULATION METHODOLOGY         41

FIGURE 8           DATA TRIANGULATION METHODOLOGY         41

2.4         RESEARCH LIMITATIONS           41

2.5         MARKET SHARE ASSESSMENT   42

2.5.1      STUDY ASSUMPTIONS  42

2.5.2      GROWTH RATE ASSUMPTIONS 43

2.6         RISK ASSESSMENT         43

TABLE 1             RISK ASSESSMENT ANALYSIS    43

2.7         RECESSION IMPACT ANALYSIS 43

3            EXECUTIVE SUMMARY 44

FIGURE 9           CONTRAST MEDIA INJECTORS MARKET, PRODUCT,  2024 VS. 2029 (USD MILLION)     44

FIGURE 10         CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 45

FIGURE 11         CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION,  2024 VS. 2029 (USD MILLION)     45

FIGURE 12         CONTRAST MEDIA INJECTORS MARKET, BY END USER,  2024 VS. 2029 (USD MILLION)             46

FIGURE 13         GEOGRAPHIC SNAPSHOT OF CONTRAST MEDIA INJECTORS MARKET            46

4            PREMIUM INSIGHTS      48

4.1         CONTRAST MEDIA INJECTORS MARKET OVERVIEW      48

FIGURE 14         GROWING ADOPTION OF CONTRAST-MEDIATED CT AND MRI DIAGNOSTIC PROCEDURES TO DRIVE MARKET             48

4.2         NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET,  BY PRODUCT AND COUNTRY (2023)           49

FIGURE 15         CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN US (2023)     49

4.3         CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION,  2024 VS. 2029 (USD MILLION)     49

FIGURE 16         INTERVENTIONAL CARDIOLOGY SEGMENT TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 49

4.4         CONTRAST MEDIA INJECTORS MARKET, BY END USER,  2024 VS. 2029 (USD MILLION) 50

FIGURE 17         DIAGNOSTIC IMAGING CENTERS SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD    50

4.5         CONTRAST MEDIA INJECTORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES           50

FIGURE 18         EMERGING MARKETS PROJECTED TO REACH HIGHER GROWTH RATES DURING FORECAST PERIOD   50

5            MARKET OVERVIEW     51

5.1         INTRODUCTION            51

5.2         MARKET DYNAMICS     51

FIGURE 19         CONTRAST MEDIA INJECTORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES       51

5.2.1      DRIVERS            52

5.2.1.1   Rising incidence of cancer and cardiovascular diseases 52

FIGURE 20         NEWLY DIAGNOSED CANCER CASES (MILLION)             52

TABLE 2             PROJECTED INCREASE IN GLOBAL NUMBER OF CANCER PATIENTS,  2020 VS. 2030 VS. 2040          53

5.2.1.2   Increasing volume of contrast-mediated MRI and CT procedures            53

TABLE 3             NUMBER OF MRI EXAMS PERFORMED PER 1,000 INHABITANTS, BY COUNTRY, 2019−2021           54

TABLE 4             NUMBER OF CT EXAMS PERFORMED PER 1,000 INHABITANTS, BY COUNTRY, 2019−2021           54

5.2.1.3   Growing approvals for CT and MRI contrast media to fuel demand for injectors              54

5.2.1.4   Favorable reimbursements in developed markets         55

5.2.2      RESTRAINTS     56

5.2.2.1   High cost of contrast media injectors             56

5.2.3      OPPORTUNITIES           57

5.2.3.1   High growth potential of emerging economies             57

5.2.3.2   Growing focus on mammography and nuclear imaging injectors 57

5.2.3.3   IT-enabled injector solutions           57

5.2.4      CHALLENGES   58

5.2.4.1   Shortage of skilled professionals and limited technical expertise 58

5.3         VALUE CHAIN ANALYSIS            59

5.3.1      RESEARCH & DEVELOPMENT   59

5.3.2      MANUFACTURING & ASSEMBLY             59

5.3.3      DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES              59

FIGURE 21         CONTRAST MEDIA INJECTORS MARKET: VALUE CHAIN ANALYSIS          60

5.4         SUPPLY CHAIN ANALYSIS          61

5.4.1      PROMINENT COMPANIES          61

5.4.2      SMALL AND MEDIUM-SIZED ENTERPRISES        61

5.4.3      END USERS       61

FIGURE 22         CONTRAST MEDIA INJECTORS MARKET: SUPPLY CHAIN ANALYSIS          61

5.5         ECOSYSTEM ANALYSIS 62

FIGURE 23         PARENT MARKET: ECOSYSTEM ANALYSIS          62

TABLE 5             CONTRAST MEDIA INJECTORS MARKET: ROLE IN ECOSYSTEM              62

5.6         REGULATORY ANALYSIS            63

TABLE 6             REGULATORY APPROVALS REQUIRED FOR CONTRAST MEDIA INJECTORS, BY COUNTRY          63

5.6.1      REGULATORY BODIES AND GOVERNMENT AGENCIES 64

5.6.1.1   North America: Regulatory bodies and government agencies     64

TABLE 7             NORTH AMERICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES         64

5.6.1.2   Europe: Regulatory bodies and government agencies   64

TABLE 8             EUROPE: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES         64

5.6.1.3   Asia Pacific: Regulatory bodies and government agencies          65

TABLE 9             ASIA PACIFIC: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES         65

5.6.1.4   Latin America: Regulatory bodies and government agencies      65

TABLE 10           LATIN AMERICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES         65

5.6.1.5   Middle East & Africa: Regulatory bodies and government agencies          66

TABLE 11           MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES         66

5.6.2      REGULATORY GUIDELINES       66

5.6.2.1   US         66

TABLE 12           US FDA: MEDICAL DEVICE CLASSIFICATION     66

TABLE 13           US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS              67

FIGURE 24         PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES        67

5.6.2.2   Canada  67

TABLE 14           CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS           67

FIGURE 25         CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES            68

5.6.2.3   Europe  69

FIGURE 26         EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES              70

5.6.2.4   Asia Pacific          70

5.6.2.4.1 Japan     70

TABLE 15           JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)    71

5.6.2.4.2 China     71

TABLE 16           CHINA: CLASSIFICATION OF MEDICAL DEVICES             71

5.6.2.4.3 India      72

5.6.2.4.4 Brazil     73

5.7         REIMBURSEMENT SCENARIO    73

TABLE 17           MEDICAL REIMBURSEMENT CODES FOR CONTRAST MEDIA IN US, 2023             73

5.8         INVESTMENT & FUNDING SCENARIO    76

FIGURE 27         NUMBER OF DEALS & FUNDING INITIATIVES IN CONTRAST MEDIA INJECTORS MARKET, 2018−2022 (USD MILLION)             76

FIGURE 28         NUMBER OF INVESTOR DEALS IN CONTRAST MEDIA INJECTORS MARKET, BY KEY PLAYER, 2018–2022             77

FIGURE 29         VALUE OF INVESTOR DEALS IN CONTRAST MEDIA INJECTORS MARKET, BY KEY PLAYER, 2018–2022 (USD MILLION)     77

5.9         PRICING ANALYSIS        77

FIGURE 30         AVERAGE SELLING PRICE TREND OF CONTRAST MEDIA INJECTORS,  BY PRODUCT       78

FIGURE 31         AVERAGE SELLING PRICE TREND OF CONTRAST MEDIA INJECTORS, BY REGION              78

TABLE 18           AVERAGE SELLING PRICE OF CONTRAST MEDIA INJECTORS, BY REGION        79

5.10       TRADE ANALYSIS          80

TABLE 19           IMPORT DATA FOR CONTRAST MEDIA INJECTORS (HS CODE 9018), BY COUNTRY,  2019–2023 (USD THOUSAND)       80

TABLE 20           EXPORT DATA FOR CONTRAST MEDIA INJECTORS (HS CODE 9018), BY COUNTRY,  2018–2022 (USD THOUSAND)       80

5.11       PATENT ANALYSIS        81

FIGURE 32         PATENT ANALYSIS: CONTRAST MEDIA INJECTORS MARKET (2013–2023)       81

5.12       PORTER’S FIVE FORCE ANALYSIS           82

TABLE 21           PORTER’S FIVE FORCES ANALYSIS: CONTRAST MEDIA INJECTORS MARKET     82

5.12.1    THREAT OF NEW ENTRANTS    82

5.12.2    THREAT OF SUBSTITUTES         82

5.12.3    BARGAINING POWER OF SUPPLIERS     82

5.12.4    BARGAINING POWER OF BUYERS           83

5.12.5    INTENSITY OF COMPETITIVE RIVALRY 83

5.13       KEY CONFERENCES & EVENTS IN 2024–2025       83

TABLE 22           LIST OF MAJOR CONFERENCES & EVENTS IN CONTRAST MEDIA INJECTORS MARKET, 2024–2025 83

5.14       CASE STUDY ANALYSIS 85

TABLE 23           CASE STUDY 1:  CARDIAC ENHANCEMENT ANALYSIS VIA CONTRAST MEDIA INJECTORS 85

5.15       TECHNOLOGY ANALYSIS           85

5.15.1    KEY TECHNOLOGIES    85

5.15.1.1 MRI contrast media injectors           85

5.15.1.2 CT contrast media injectors             86

5.15.1.3 Angiography contrast media injectors            87

5.15.2    COMPLEMENTARY TECHNOLOGIES     88

5.15.2.1 Diagnostic imaging modalities         88

5.15.3    ADJACENT TECHNOLOGIES      88

5.15.3.1 Artificial intelligence with automated data systems       88

5.16       TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 88

FIGURE 33         REVENUE SHIFT IN CONTRAST MEDIA INJECTORS MARKET              89

5.17       KEY STAKEHOLDERS & BUYING CRITERIA          89

5.17.1    KEY STAKEHOLDERS IN BUYING PROCESS         89

FIGURE 34         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PRIMARY FACTORS       89

TABLE 24           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 90

FIGURE 35         BUYING CRITERIA FOR END USERS        90

TABLE 25           INFLUENCE OF END USERS ON BUYING PROCESS          90

FIGURE 36         INFLUENCE OF STAKEHOLDERS. BY END USER 91

TABLE 26           INFLUENCE OF STAKEHOLDERS, BY END USER 91

5.17.2    BUYING CRITERIA         91

FIGURE 37         KEY BUYING CRITERIA FOR PROCESS CONTRAST MEDIA INJECTORS        91

TABLE 27           KEY BUYING CRITERIA FOR CONTRAST MEDIA INJECTORS              92

5.18       UNMET NEEDS & KEY PAIN POINTS       92

TABLE 28           CONTRAST MEDIA INJECTORS MARKET: CURRENT UNMET NEEDS 92

5.19       ARTIFICIAL INTELLIGENCE (AI) IN CONTRAST MEDIA INJECTORS MARKET            93

6            CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT 94

6.1         INTRODUCTION            95

TABLE 29           CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     95

6.2         INJECTOR SYSTEMS      95

TABLE 30           CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)          95

TABLE 31           CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)          96

6.2.1      CT INJECTORS  96

6.2.1.1   Increasing number of CT scans to boost demand         96

TABLE 32           CT INJECTORS MARKET, BY REGION, 2022–2029 (USD MILLION)              96

6.2.2      MRI INJECTORS 97

6.2.2.1   Rising funding initiatives for development of advanced systems to propel market              97

TABLE 33           MRI INJECTORS MARKET, BY REGION, 2022–2029 (USD MILLION)          97

6.2.3      ANGIOGRAPHY INJECTORS       98

6.2.3.1   High uptake of cardiac catheterization procedures to drive market           98

TABLE 34           ANGIOGRAPHY INJECTORS MARKET, BY REGION, 2022–2029 (USD MILLION) 98

6.2.4      OTHER INJECTORS        98

6.3         CONSUMABLES 99

TABLE 35           CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)     99

TABLE 36           CONTRAST MEDIA CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)     99

6.3.1      SYRINGES          99

6.3.1.1   Diverse size range to fuel uptake      99

TABLE 37           SYRINGES MARKET, BY REGION, 2022–2029 (USD MILLION)              100

6.3.2      TUBES  100

6.3.2.1   Increasing demand for single-use products to drive market        100

TABLE 38           TUBES MARKET, BY REGION, 2022–2029 (USD MILLION) 100

6.3.3      OTHER CONSUMABLES 100

TABLE 39           OTHER CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)          101

6.4         ACCESSORIES   101

6.4.1      ABILITY TO ENHANCE WORKFLOW EFFICIENCY TO SUPPORT MARKET GROWTH        101

TABLE 40           CONTRAST MEDIA ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)     101

7            CONTRAST MEDIA INJECTORS MARKET, BY TYPE          102

7.1         INTRODUCTION            103

TABLE 41           CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 103

7.2         SINGLE-HEAD INJECTORS         103

7.2.1      COST-EFFICIENT AND USER-FRIENDLY DESIGN TO PROPEL MARKET              103

TABLE 42           CONTRAST MEDIA INJECTORS MARKET FOR SINGLE-HEAD INJECTORS, BY REGION, 2022–2029 (USD MILLION)        103

7.3         DUAL-HEAD INJECTORS            104

7.3.1      PRECISE CONTROL AND ENHANCED PATIENT SAFETY TO BOOST DEMAND           104

TABLE 43           CONTRAST MEDIA INJECTORS MARKET FOR DUAL-HEAD INJECTORS, BY REGION, 2022–2029 (USD MILLION)        104

7.4         SYRINGELESS INJECTORS          104

7.4.1      DIRECT ADMINISTRATION VIA TUBING TO SUPPORT MARKET GROWTH          104

TABLE 44           CONTRAST MEDIA INJECTORS MARKET FOR SYRINGELESS INJECTORS, BY REGION, 2022–2029 (USD MILLION)        105

8            CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION        106

8.1         INTRODUCTION            107

TABLE 45           CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          107

8.2         RADIOLOGY     107

8.2.1      RISING NUMBER OF RADIOLOGY PROCEDURES TO DRIVE MARKET              107

TABLE 46           CONTRAST MEDIA INJECTORS MARKET FOR RADIOLOGY, BY REGION,  2022–2029 (USD MILLION)     107

8.3         INTERVENTIONAL CARDIOLOGY          108

8.3.1      RISING UPTAKE OF CORONARY CT ANGIOGRAMS TO PROPEL MARKET            108

TABLE 47           CONTRAST MEDIA INJECTORS MARKET FOR INTERVENTIONAL CARDIOLOGY, BY REGION, 2022–2029 (USD MILLION)              108

8.4         INTERVENTIONAL RADIOLOGY             109

8.4.1      INCREASING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO SUPPORT MARKET GROWTH           109

TABLE 48           CONTRAST MEDIA INJECTORS MARKET FOR INTERVENTIONAL RADIOLOGY, BY REGION, 2022–2029 (USD MILLION) 109

9            CONTRAST MEDIA INJECTORS MARKET, BY END USER 110

9.1         INTRODUCTION            111

TABLE 49           CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022–2029 (USD MILLION)     111

9.2         HOSPITALS       111

9.2.1      HIGH PURCHASING POWER FOR ADVANCED EQUIPMENT TO SUPPORT MARKET GROWTH    111

TABLE 50           CONTRAST MEDIA INJECTORS MARKET FOR HOSPITALS, BY REGION,  2022–2029 (USD MILLION)     112

9.3         DIAGNOSTIC IMAGING CENTERS          112

9.3.1      INCREASING ESTABLISHMENT OF PRIVATE IMAGING CENTERS TO PROPEL MARKET          112

TABLE 51           CONTRAST MEDIA INJECTORS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2022–2029 (USD MILLION)       112

10          CONTRAST MEDIA INJECTORS MARKET, BY REGION     113

10.1       INTRODUCTION            114

TABLE 52           CONTRAST MEDIA INJECTORS MARKET, BY REGION, 2022–2029 (USD MILLION) 114

10.2       NORTH AMERICA          114

FIGURE 38         NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET SNAPSHOT        115

TABLE 53           NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 115

TABLE 54           NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT,  2022–2029 (USD MILLION) 116

TABLE 55           NORTH AMERICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION) 116

TABLE 56           NORTH AMERICA: CONTRAST MEDIA INJECTORS CONSUMABLES MARKET, BY TYPE,  2022–2029 (USD MILLION) 116

TABLE 57           NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY TYPE,  2022–2029 (USD MILLION)          117

TABLE 58           NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION,  2022–2029 (USD MILLION)        117

TABLE 59           NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY END USER,  2022–2029 (USD MILLION) 117

10.2.1    NORTH AMERICA: RECESSION IMPACT 117

10.2.2    US         118

10.2.2.1 Rising adoption of technologically advanced products to drive market      118

TABLE 60           US: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          118

TABLE 61           US: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)          119

TABLE 62           US: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          119

10.2.3    CANADA            119

10.2.3.1 Rising investments in medical imaging equipment to drive market           119

TABLE 63           CANADA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT,  2022–2029 (USD MILLION) 120

TABLE 64           CANADA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)          120

TABLE 65           CANADA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)             121

10.3       EUROPE             121

TABLE 66           EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 121

TABLE 67           EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT,  2022–2029 (USD MILLION) 122

TABLE 68           EUROPE: CONTRAST MEDIA INJECTORS SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)          122

TABLE 69           EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY TYPE,  2022–2029 (USD MILLION)          122

TABLE 70           EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION,  2022–2029 (USD MILLION)        123

TABLE 71           EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY END USER,  2022–2029 (USD MILLION)          123

10.3.1    EUROPE: RECESSION IMPACT   123

10.3.2    GERMANY         123

10.3.2.1 Advancements in imaging technologies to fuel uptake  123

TABLE 72           GERMANY: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT,  2022–2029 (USD MILLION) 124

TABLE 73           GERMANY: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)    124

TABLE 74           GERMANY: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE,  2022–2029 (USD MILLION)          125

10.3.3    FRANCE             125

10.3.3.1 Increasing prevalence of cancer to propel market         125

TABLE 75           FRANCE: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT,  2022–2029 (USD MILLION) 125

TABLE 76           FRANCE: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)          126

TABLE 77           FRANCE: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE,  2022–2029 (USD MILLION)          126

10.3.4    UK         126

10.3.4.1 High incidence of CVD to propel market       126

TABLE 78           UK: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          127

TABLE 79           UK: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)          127

TABLE 80           UK: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          128

10.3.5    ITALY   128

10.3.5.1 Rising incidence of chronic diseases to support market growth   128

TABLE 81           ITALY: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          128

TABLE 82           ITALY: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)          129

TABLE 83           ITALY: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          129

10.3.6    SPAIN   129

10.3.6.1 Shortage of skilled radiologists to restrain market         129

TABLE 84           SPAIN: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          130

TABLE 85           SPAIN: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)          130

TABLE 86           SPAIN: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          130

10.3.7    REST OF EUROPE           131

TABLE 87           REST OF EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT,  2022–2029 (USD MILLION) 131

TABLE 88           REST OF EUROPE: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION) 132

TABLE 89          REST OF EUROPE: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE,  2022–2029 (USD MILLION)    132

10.4       ASIA PACIFIC    132

FIGURE 39         ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET SNAPSHOT        133

TABLE 90           ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 134

TABLE 91           ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT,  2022–2029 (USD MILLION) 134

TABLE 92          ASIA PACIFIC: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)    134

TABLE 93           ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY TYPE,  2022–2029 (USD MILLION)          135

TABLE 94           ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION,  2022–2029 (USD MILLION)        135

TABLE 95           ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY END USER,  2022–2029 (USD MILLION)          135

10.4.1    ASIA PACIFIC: RECESSION IMPACT        135

10.4.2    JAPAN  136

10.4.2.1 Rising geriatric population and subsequent increase in chronic diseases to drive market   136

TABLE 96           JAPAN: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          136

TABLE 97           JAPAN: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)          137

TABLE 98           JAPAN: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          137

10.4.3    CHINA  137

10.4.3.1 Rising incidence of cancer and increasing establishment of hospitals to boost demand 137

TABLE 99           CHINA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          138

TABLE 100         CHINA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)          138

TABLE 101         CHINA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          138

10.4.4    INDIA   139

10.4.4.1 Growing investments in radiology to propel market     139

TABLE 102         INDIA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)          139

TABLE 103         INDIA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)          140

TABLE 104         INDIA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)          140

10.4.5    AUSTRALIA       140

10.4.5.1 Increasing R&D investments for advanced diagnostic modalities to drive market              140

TABLE 105         AUSTRALIA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT,  2022–2029 (USD MILLION) 141

TABLE 106         AUSTRALIA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)    141

TABLE 107         AUSTRALIA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE,  2022–2029 (USD MILLION)          142

10.4.6    SOUTH KOREA 142

10.4.6.1 Favorable reimbursements for diagnostic procedures to support market growth              142

TABLE 108         SOUTH KOREA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT,  2022–2029 (USD MILLION) 142

TABLE 109         SOUTH KOREA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION) 143

TABLE 110         SOUTH KOREA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE,  2022–2029 (USD MILLION)    143

10.4.7    REST OF ASIA PACIFIC  143

TABLE 111         REST OF ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        144

TABLE 112         REST OF ASIA PACIFIC: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)    144

TABLE 113         REST OF ASIA PACIFIC: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE,  2022–2029 (USD MILLION) 145

10.5       LATIN AMERICA             145

TABLE 114         LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 145

TABLE 115         LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT,  2022–2029 (USD MILLION) 146

TABLE 116         LATIN AMERICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION) 146

TABLE 117         LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY TYPE,  2022–2029 (USD MILLION)          146

TABLE 118         LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION,  2022–2029 (USD MILLION)        147

TABLE 119         LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY END USER,  2022–2029 (USD MILLION) 147

10.5.1    LATIN AMERICA: RECESSION IMPACT   147

10.5.2    BRAZIL 148

10.5.2.1 Growing awareness of early disease detection & diagnosis to drive market              148

TABLE 120        BRAZIL: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT,  2022–2029 (USD MILLION)          148

TABLE 121         BRAZIL: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)          148

TABLE 122         BRAZIL: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE,  2022–2029 (USD MILLION)          149

10.5.3    MEXICO             149

10.5.3.1 Inadequate healthcare infrastructure to restrain market             149

TABLE 123         MEXICO: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT,  2022–2029 (USD MILLION) 149

TABLE 124         MEXICO: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)          150

TABLE 125         MEXICO: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE,  2022–2029 (USD MILLION)          150

10.5.4    REST OF LATIN AMERICA          150

TABLE 126         REST OF LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)        151

TABLE 127         REST OF LATIN AMERICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 151

TABLE 128         REST OF LATIN AMERICA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)    151

10.6       MIDDLE EAST & AFRICA             152

10.6.1    IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET            152

TABLE 129         MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT,  2022–2029 (USD MILLION)      152

TABLE 130         MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE,  2022–2029 (USD MILLION)            153

TABLE 131         MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY TYPE,  2022–2029 (USD MILLION) 153

TABLE 132         MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION,  2022–2029 (USD MILLION)             153

TABLE 133         MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY END USER,  2022–2029 (USD MILLION)      154

10.6.2    MIDDLE EAST & AFRICA: RECESSION IMPACT   154

11          COMPETITIVE LANDSCAPE       155

11.1       OVERVIEW        155

11.2       KEY PLAYER STRATEGIES/RIGHT TO WIN          155

11.2.1    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CONTRAST MEDIA INJECTORS MARKET      155

TABLE 134         OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES             155

11.3       REVENUE ANALYSIS      156

FIGURE 40         REVENUE SHARE ANALYSIS OF TOP PLAYERS IN CONTRAST MEDIA INJECTORS MARKET (2019−2023)           157

11.4       MARKET SHARE ANALYSIS         157

FIGURE 41         MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)        157

TABLE 135         CONTRAST MEDIA INJECTORS MARKET: DEGREE OF COMPETITION 158

11.4.1    RANKING OF KEY MARKET PLAYERS     159

FIGURE 42         RANKING OF KEY PLAYERS IN CONTRAST MEDIA INJECTORS MARKET, 2023  159

11.5       COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023   159

11.5.1    STARS  159

11.5.2    EMERGING LEADERS    159

11.5.3    PERVASIVE PLAYERS     159

11.5.4    PARTICIPANTS 160

FIGURE 43         CONTRAST MEDIA INJECTORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023      160

11.5.5    COMPANY FOOTPRINT: KEY PLAYERS, 2023      161

11.5.5.1 Company footprint            161

FIGURE 44         CONTRAST MEDIA INJECTORS MARKET: COMPANY FOOTPRINT      161

11.5.5.2 Product footprint 161

TABLE 136         CONTRAST MEDIA INJECTORS MARKET: PRODUCT FOOTPRINT      161

11.5.5.3 Application footprint         162

TABLE 137         CONTRAST MEDIA INJECTORS MARKET: APPLICATION FOOTPRINT      162

11.5.5.4 End-user footprint             163

TABLE 138         CONTRAST MEDIA INJECTORS MARKET: END-USER FOOTPRINT      163

11.5.5.5 Region footprint  164

TABLE 139         CONTRAST MEDIA INJECTORS MARKET: REGION FOOTPRINT              164

11.6       COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023          164

11.6.1    PROGRESSIVE COMPANIES       164

11.6.2    RESPONSIVE COMPANIES          164

11.6.3    DYNAMIC COMPANIES 165

11.6.4    STARTING BLOCKS       165

FIGURE 45         CONTRAST MEDIA INJECTORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 165

11.6.5    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023             166

TABLE 140         CONTRAST MEDIA INJECTORS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS    166

TABLE 141         CONTRAST MEDIA INJECTORS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS        167

11.7       COMPANY VALUATION & FINANCIAL METRICS 168

11.7.1    FINANCIAL METRICS    168

FIGURE 46         EV/EBITDA OF KEY VENDORS   168

11.7.2    COMPANY VALUATION 168

FIGURE 47         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF  KEY VENDORS           168

11.8       BRAND/PRODUCT COMPARISON          169

FIGURE 48         CONTRAST MEDIA INJECTORS MARKET: BRAND/PRODUCT COMPARISON ANALYSIS            169

11.9       COMPETITIVE SCENARIO          169

11.9.1    PRODUCT LAUNCHES & APPROVALS    169

TABLE 142         CONTRAST MEDIA INJECTORS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024      169

11.9.2    DEALS  170

TABLE 143         CONTRAST MEDIA INJECTORS MARKET: DEALS, JANUARY 2021–MAY 2024 170

11.9.3    EXPANSIONS    170

TABLE 144         CONTRAST MEDIA INJECTORS MARKET: EXPANSIONS, JANUARY 2021–MAY 2024            170

12          COMPANY PROFILES    171

12.1       KEY PLAYERS   171

(Business overview, Products offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and Competitive threats)*

12.1.1    BAYER AG          171

TABLE 145         BAYER AG: COMPANY OVERVIEW          171

FIGURE 49         BAYER AG: COMPANY SNAPSHOT (2023)            172

TABLE 146         BAYER AG: PRODUCTS OFFERED           172

TABLE 147         BAYER AG: DEALS, JANUARY 2021−MAY 2024    173

12.1.2    BRACCO IMAGING S.P.A.            175

TABLE 148         BRACCO IMAGING S.P.A.: COMPANY OVERVIEW             175

TABLE 149         BRACCO IMAGING S.P.A.: PRODUCTS OFFERED 175

TABLE 150         BRACCO IMAGING S.P.A.: DEALS, JANUARY 2021−MAY 2024              176

TABLE 151         BRACCO IMAGING S.P.A.: EXPANSIONS, JANUARY 2021−MAY 2024      176

12.1.3    GUERBET          177

TABLE 152         GUERBET: COMPANY OVERVIEW           177

FIGURE 50         GUERBET: COMPANY SNAPSHOT (2023)             178

TABLE 153         GUERBET: PRODUCTS OFFERED            178

TABLE 154         GUERBET: PRODUCT LAUNCHES, JANUARY 2021−MAY 2024              179

12.1.4    ULRICH GMBH & CO. KG            180

TABLE 155         ULRICH GMBH & CO. KG: COMPANY OVERVIEW             180

TABLE 156         ULRICH GMBH & CO. KG: PRODUCTS OFFERED 180

TABLE 157         ULRICH GMBH & CO. KG: DEALS, JANUARY 2021−MAY 2024              181

12.1.5    MEDTRON AG  182

TABLE 158         MEDTRON AG.: COMPANY OVERVIEW  182

TABLE 159         MEDTRON AG: PRODUCTS OFFERED    182

TABLE 160         MEDTRON AG: DEALS, JANUARY 2021−MAY 2024           183

12.1.6    NEMOTO KYORINDO CO., LTD. 184

TABLE 161         NEMOTO KYORINDO CO., LTD.: COMPANY OVERVIEW 184

TABLE 162         NEMOTO KYORINDO CO., LTD.: PRODUCTS OFFERED 184

12.1.7    SHENZHEN ANKE HIGH-TECH CO., LTD.            185

TABLE 163         SHENZHEN ANKE HIGH-TECH CO., LTD.: COMPANY OVERVIEW        185

TABLE 164         SHENZHEN ANKE HIGH-TECH CO., LTD.: PRODUCTS OFFERED              185

12.1.8    SINO MDT         186

TABLE 165         SINO MDT: COMPANY OVERVIEW         186

TABLE 166         SINO MDT: PRODUCTS OFFERED          186

12.1.9    APOLLO RT CO., LTD.   187

TABLE 167         APOLLO RT CO., LTD.: COMPANY OVERVIEW   187

TABLE 168         APOLLO RT CO., LTD.: PRODUCTS OFFERED    187

12.1.10  SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.         188

TABLE 169         SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: COMPANY OVERVIEW  188

TABLE 170         SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: PRODUCTS OFFERED   188

12.1.11  SHENZHEN ANTMED CO., LTD. 189

TABLE 171         SHENZHEN ANTMED CO., LTD.: COMPANY OVERVIEW 189

TABLE 172         SHENZHEN ANTMED CO., LTD.: PRODUCTS OFFERED  189

12.1.12  SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD.           190

TABLE 173         SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW  190

TABLE 174         SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED   190

12.1.13  UNION MEDICAL SHENZHEN CO., LTD. 191

TABLE 175         UNION MEDICAL SHENZHEN CO., LTD.: COMPANY OVERVIEW              191

TABLE 176         UNION MEDICAL SHENZHEN CO., LTD.: PRODUCTS OFFERED              191

12.1.14  SPECTRUM MEDICAL TECHNOLOGIES 192

TABLE 177         SPECTRUM MEDICAL TECHNOLOGIES: COMPANY OVERVIEW              192

TABLE 178         SPECTRUM MEDICAL TECHNOLOGIES: PRODUCTS OFFERED              192

12.1.15  SHENZHEN BOON MEDICAL SUPPLY CO., LTD. 193

TABLE 179         SHENZHEN BOON MEDICAL SUPPLY CO., LTD.: COMPANY OVERVIEW        193

TABLE 180         SHENZHEN BOON MEDICAL SUPPLY CO., LTD.: PRODUCTS OFFERED          193

12.2       OTHER PLAYERS           194

12.2.1    SCW MEDICATH LTD.: COMPANY OVERVIEW    194

12.2.2    VYGON: COMPANY OVERVIEW 194

12.2.3    NANJING FOINOE CO., LTD.: COMPANY OVERVIEW       195

12.2.4    LEMER PAX: COMPANY OVERVIEW        195

12.2.5    COMECER S.P.A.: COMPANY OVERVIEW             196

12.2.6    TEMA SINERGIE S.P.A.: COMPANY OVERVIEW   196

12.2.7    SHEEN MAN CO., LTD.: COMPANY OVERVIEW   197

12.2.8    HONG KONG MEDI CO., LTD.: COMPANY OVERVIEW    197

12.2.9    QINGDAO HIPROVE MEDICAL TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW        198

12.2.10  SHANGHAI KINDLY ENTERPRISE DEVELOPMENT GROUP CO., LTD: COMPANY OVERVIEW  198

*Details on Business overview, Products offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and Competitive threats might not be captured in case of unlisted companies.

13          APPENDIX         199

13.1       DISCUSSION GUIDE      199

13.2       KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL             203

13.3       CUSTOMIZATION OPTIONS      205

13.4       RELATED REPORTS       205

13.5       AUTHOR DETAILS         206

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧